Analytical Method Development and Validation of Ademetionine: A Detailed Review

Ademetionine, commonly known as S-Adenosyl-L-methionine (SAMe), is a pivotal biological compound involved in methylation, neurotransmitter synthesis, glutathione production, and liver detoxification. This compound is widely studied for its therapeutic potential in depression, osteoarthritis, and liver diseases. The analysis of SAMe in pharmaceutical formulations and biological samples requires robust analytical methodologies due to its sensitivity to environmental factors like pH, light, and temperature. Key analytical techniques include High-Performance Liquid Chromatography (HPLC), often coupled with fluorescence or mass spectrometry detection, which provides high specificity and sensitivity. Other methods, such as Capillary Electrophoresis (CE), UV detection, and Nuclear Magnetic Resonance (NMR), offer complementary insights into its quantification, structural elucidation, and purity. Method development involves optimizing parameters like mobile phase composition, pH control, and sample preparation to ensure stability and accurate detection. Validation processes adhere to ICH guidelines, emphasizing specificity, linearity, accuracy, precision, and robustness. Therapeutically, SAMe is utilized for its hepatoprotective properties, mood-enhancing effects, and potential to alleviate osteoarthritis symptoms. Despite its benefits, careful administration is advised due to side effects like gastrointestinal disturbances and the risk of mania in individuals with bipolar disorder. This review underscores the importance of precise analytical methods for quality control and pharmacokinetic studies, facilitating the clinical and pharmaceutical applications of SAMe.